5th Circular and SaRNA Therapeutics Summit 2026

The 5th Circular and Self-Amplifying RNA Therapeutics Summit is the only industry forum dedicated exclusively to translating circRNA and saRNA into durable, IND-ready medicines. As the RNA field moves beyond linear mRNA, these next-generation modalities are emerging as the solution to short-lived expression, high dosing requirements, and limited therapeutic reach.

With first-in-human trials now underway, increasing regulatory engagement, and expanding applications across oncology, autoimmune disease, and in vivo CAR-T, 2026 represents a critical inflection point. Developers must now prove not just promise, but performance, from durability and immunogenicity control to delivery, manufacturability, and IP strategy.

Held in Boston from May 26–28, 2026, this summit brings together senior leaders from biotech, pharma, and academia, including teams from CirCode Biomed, Replicate Bioscience, Sail Biomedicines, Strand Therapeutics, HDT Bio, and Altamira Therapeutics. Across data-driven case studies, expert panels, and deep-dive workshops, attendees will gain practical insight into advancing circular and self-amplifying RNA programs toward the clinic.

If you are building, validating, or scaling next-generation m-RNA platforms, this is the definitive meeting to attend in 2026.

URLs:
Website: https://go.evvnt.com/3484124-0?pid=2874
Brochure: https://go.evvnt.com/3484124-3?pid=2874

Category: Conferences | Science, Health and Medicine | Pharmaceuticals

Prices:
Drug developer Pricing - Conference + 2 Workshops: USD 4297.00,
Drug developer Pricing - Conference + 1 Workshops: USD 3698.00,
Drug developer Pricing - Conference Only: USD 3099.00,
Academic Pricing - Conference + 2 Workshops: USD 3697.00,
Academic Pricing - Conference + 1 Workshops: USD 3198.00,
Academic Pricing - Conference Only: USD 2699.00,
Service Provider Pricing - Conference + 2 Workshops: USD 5197.00,
Service Provider Pricing - Conference + 1 Workshops: USD 4498.00,
Service Provider Pricing - Conference Only: USD 3799.00

Speakers: Dan Shores, Partner, Rothwell Figg, Christopher Jewell, Professor of Translational Engineering, University of Maryland, College Park, Anna Blakney, Assistant Professor, University of British Columbia, Chenxiang Tang, Chief Executive Officer, Circode Biomed, Marc Talló-Parra, Chief Scientific Officer, NoctuRNA Therapeutics, Darina Spasova, Senior Scientific Director, Replicate Bioscience, Covadonga Paneda, Chief Operating Officer, Altamira Therapeutics, Jesse Kuiper, Principal Scientist in Vaccines Analytical R and D, Merck and Co, Justin Letendre, Synthetic Biology Scientist, Strand Therapeutics Inc., Yingzhong Li, President, SunVax mRNA Therapeutics, Josh McGee, CSO, Keylicon Biosciences, Michael Mingueneau, Vice President - Immunology, Sail Biomedicines, Kevin Heyeck, Chief Executive Officer and Director, Chimeron Bio, Thomas Hansen, Chief Technology Officer, Circio ASA, Mardin Fallah, Chief Executive Officer and Founder, RNARevive, Jesse Erasmus, Director, Virology, HDT Bio, Thimmaiah Chendrimada, Founder, Able Sciences